WASHINGTON – Drug makers on Thursday voluntarily pulled kids’ cold medicines off the market less than two weeks after the government warned of potential health risks to infants.
if(window.yzq_d==null)window.yzq_d=new Object();
window.yzq_d[‘.M.BqULEYrI-‘]=’&U=13bthuli2%2fN%3d.M.BqULEYrI-%2fC%3d609072.11521328.12052419.1442997%2fD%3dLREC%2fB%3d4942996’;
Products aimed at children under the age of two are being removed from store shelves due to “rare instantances of misuse” that could lead to accidental overdose, a trade group that represents over-the-counter drug makers said.
Cold medicines being withdrawn include: Johnson & Johnson Pediacare Infant Drops and Tylenol Concentrated Infants Drops, Wyeth‘s Dimetapp Decongestant Infant Drops, Novartis’ Triaminic Infant & Toddler Thin Strips and Prestige Brands Holdings’ Little Colds Decongestant Plus Cough.
More info: